These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26281610)

  • 1. [Enlightenment of adverse reaction monitoring on safety evaluation of traditional Chinese medicines].
    Song HB; Du XX; Ren JT; Yang L; Guo XX; Pang Y
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(8):1620-3. PubMed ID: 26281610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishment of model of traditional Chinese medicine injections post-marketing safety monitoring].
    Guo XE; Zhao YB; Xie YM; Zhao LC; Li YF; Hao Z
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2974-8. PubMed ID: 24471314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary study on general safe medication regularity of Chinese patent orthopedic medicines based on adverse reaction/event literature analysis].
    Wang YG; Shi XY; Jin R; Li HY; Kong XW; Qiao YJ
    Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1192-7. PubMed ID: 26226769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Establish research model of post-marketing clinical safety evaluation for Chinese patent medicine].
    Zheng WK; Liu Z; Lei X; Tian R; Zheng R; Li N; Ren JT; Du XX; Shang HC
    Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(18):3693-6. PubMed ID: 26983223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Technical specifications for intensive hospital safety monitoring of post-marketing Chinese medicine (draft version for comments)].
    Xie YM; Liao X; Zhao YB; Li MQ; Zhang YL; Ma R; Xian SX; Liu J; Li SY; Wen ZH; Yang ZQ; Zou JD; Sun HS; He Y; Li XL; Jiang JJ; Wang ZF; Li YY; Wang LX; Chang YP; Yang W; Zhang W
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2919-24. PubMed ID: 24471304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison and analysis of clinical safety evaluation methods for parenterally administered Chinese medicine].
    Yan BH; Peng C; Xie YM; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2979-82. PubMed ID: 24471315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Re-evaluation upon suspected event" is an approach for post-marketing clinical study: lessons from adverse drug events related to Bupleuri Radix preparations].
    Wu SX; Sun HF; Yang XH; Long HZ; Ye ZG; Ji SL; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(15):2983-8. PubMed ID: 25423845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reevaluation on adverse reaction monitoring and safety of proprietary Chinese medicines of Chongqing from 2005 to 2011].
    Yang YY; Dong Z; Zhu SB; Sun HF; Yang MP
    Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3659-63. PubMed ID: 23477159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reduction of ADRs of essential traditional Chinese medicines].
    Nie Q; Liu Y; Chen J
    Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(2):340-344. PubMed ID: 28861983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To establish a body of evidence on safety for postmarketing Chinese medicine: A new research paradigm.
    Liao X; Xie YM; Robinson N; Wang YY
    Chin J Integr Med; 2017 Mar; 23(3):226-232. PubMed ID: 27900605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
    Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety research in Chinese medicines based on application of data mining].
    Tong Y; Yang J; Li C; He W
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):3047-50. PubMed ID: 22308699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress of adverse reactions of traditional Chinese medicine injections].
    Tan LJ; Wang M; Zhu Y
    Zhongguo Zhong Yao Za Zhi; 2014 Oct; 39(20):3889-98. PubMed ID: 25751935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analyze causes of adverse reactions induced by traditional Chinese medicine injections from its quality standards].
    Cui HY; Liang AH
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):934-40. PubMed ID: 25204194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A discussion of key issues on postmarketing reevaluation of Chinese medicine].
    Xie Y; Tian F
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1494-7. PubMed ID: 20822029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Post-marketing reevaluation for potential quality risk and quality control in clinical application of traditional Chinese medicines].
    Li HJ; He LY; Liu BY
    Zhongguo Zhong Yao Za Zhi; 2015 Jun; 40(12):2461-3. PubMed ID: 26591543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Academic discussion of adverse reaction of clinical trials of new traditional Chinese medicines and relevant influencing factors].
    Wang WP; Yu M; Wang L; Jiang XR; Li XB; Wang HW; Cao Y; Liu K; Huang LQ
    Zhongguo Zhong Yao Za Zhi; 2015 Jan; 40(2):346-50. PubMed ID: 26080571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of rational clinical uses of traditional Chinese medicine injections and factors influencing adverse drug reactions].
    Sun SG; Li ZF; Xie YM; Liu J; Lu Y; Song YF; Han YH; Liu LD; Peng TT
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2969-73. PubMed ID: 24471313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research on early warning signals of adverse drug reactions to parenterally administered xiyanping based on spontaneous reporting system (SRS) data].
    Wang ZF; Xiang YY; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):3008-12. PubMed ID: 24471321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of quality traceability system of traditional Chinese medicine].
    Cai Y; Hu H; Ni JY; Wang YT
    Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(22):3829-33. PubMed ID: 24558859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.